Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1990-4-12
|
pubmed:abstractText |
To compare the merits of 123I-isopropyl-iodoamphetamine (123I-IMP) and 99mTc-HMPAO in showing abnormal brain uptake distribution during cerebral ischemia, we studied ten patients during the subacute phase of their stroke, a period where metabolism and blood flow are frequently uncoupled. SPECT imaging was performed using both radiopharmaceuticals in the 10 patients from 48 h to 4 weeks after onset of symptoms. Two patients out of the 10 had similar defects with 123I-IMP and 99mTc-HMPAO SPECT, the location of the defects corresponding to the area of infarction observed on CT. Six patients had normal 99mTc-HMPAO SPECT and abnormal 123I-IMP SPECT with defects in the area of infarction shown by CT. The remaining 2 patients had hyperactive abnormalities on 99mTc-HMPAO in areas corresponding to defects on the 123I-IMP images. Two of the patients with SPECT mismatches were studied again more than 1 month after onset. On reexamination, 99mTc-HMPAO SPECT which was previously normal or hyperactive became hypoactive with a focal area of decreased activity corresponding to the defect on 123I-IMP. Crossed cerebellar diaschisis was found in 7 patients with 99mTc-HMPAO and was absent for both 123I-IMP and 99mTc-HMPAO in 3. We suggest that SPECT with 99mTc-HMPAO could show transient hyperemia not demonstrated by 123I-IMP whereas in some cases cerebral infarction would be more difficult to demonstrate with 99mTc-HMPAO than with 123I-IMP. SPECT with both tracers is recommended to follow the evolution of strokes in terms of regional cerebral blood flow and tissue metabolism.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amphetamines,
http://linkedlifedata.com/resource/pubmed/chemical/Iodine Radioisotopes,
http://linkedlifedata.com/resource/pubmed/chemical/Iofetamine,
http://linkedlifedata.com/resource/pubmed/chemical/Organotechnetium Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Oximes,
http://linkedlifedata.com/resource/pubmed/chemical/Technetium Tc 99m Exametazime
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0340-6997
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
17-22
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2307169-Adult,
pubmed-meshheading:2307169-Aged,
pubmed-meshheading:2307169-Aged, 80 and over,
pubmed-meshheading:2307169-Amphetamines,
pubmed-meshheading:2307169-Cerebrovascular Circulation,
pubmed-meshheading:2307169-Cerebrovascular Disorders,
pubmed-meshheading:2307169-Female,
pubmed-meshheading:2307169-Humans,
pubmed-meshheading:2307169-Iodine Radioisotopes,
pubmed-meshheading:2307169-Iofetamine,
pubmed-meshheading:2307169-Male,
pubmed-meshheading:2307169-Middle Aged,
pubmed-meshheading:2307169-Organotechnetium Compounds,
pubmed-meshheading:2307169-Oximes,
pubmed-meshheading:2307169-Technetium Tc 99m Exametazime,
pubmed-meshheading:2307169-Tomography, Emission-Computed, Single-Photon
|
pubmed:year |
1990
|
pubmed:articleTitle |
"Luxury perfusion" with 99mTc-HMPAO and 123I-IMP SPECT imaging during the subacute phase of stroke.
|
pubmed:affiliation |
Department of Medical Neurosciences, C.H.U. Henri Mondor, Créteil, France.
|
pubmed:publicationType |
Journal Article
|